Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Unexpected brain structures tied to creativity, and to stifling it

  • Researchers tie unexpected brain structures to creativity -- and to stifling it

  • Study identifies brain regions activated when pain intensity doesn't match expectation

  • Differences in RORA levels in brain may contribute to autism sex bias

  • Imaging test may identify biomarker of Alzheimer's disease

  • Flood aftermath linked to post-traumatic stress, study shows

  • Breakthrough measures Parkinson's progression in brain

  • Study identifies possible role for carbon monoxide in treating hemorrhagic stroke

  • Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies

  • New findings about mechanisms underlying chronic pain reveal novel therapeutic strategies

  •